Unlike anti-tumor neutrophils, pro-tumor neutrophils express low HLA-DR and CD74; rather, they exhibit Programmed death-ligand 1 (PDL-1), CD66b, and CD15, which contribute to immunosuppression in the tumor microenvironment [63]. This evidence concerns the gene CD274 and neoplasm.